Your $20B sales projection is a stretch, IMO. You must be assuming MRK’s compound produces stellar phase-3 data while all competing compounds fail, which is not a likely outcome.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”